Clinical trial
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
NCT05592938
Study timeline
Study start (actual)2023-06-27Date precision: day
Registry last updated2026-07-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Breast Cancer Recurrentunresolved
Interventions
rPBIRADIATION
Sponsors & collaborators
University Health Network, Torontolead sponsor
Sunnybrook Health Sciences Centrecollaborator
Royal Victoria Regional Health Centrecollaborator
AC Camargo Cancer Centercollaborator
King Hussein Cancer Centercollaborator
NYU Langone Healthcollaborator
Peter MacCallum Cancer Centre, Australiacollaborator
CHU de Quebec-Universite Lavalcollaborator
Tel-Aviv Sourasky Medical Centercollaborator
Virginia Commonwealth Universitycollaborator
AOU Careggicollaborator
Maisonneuve-Rosemont Hospitalcollaborator
Columbia Universitycollaborator
Lakeridge Healthcollaborator
London Health Sciences Centrecollaborator
Clínica IRAMcollaborator
University of Malayacollaborator
Aga Khan Universitycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05592938 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.